BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30015920)

  • 41. CircCDKN2B-AS1 interacts with IMP3 to stabilize hexokinase 2 mRNA and facilitate cervical squamous cell carcinoma aerobic glycolysis progression.
    Zhang Y; Zhao L; Yang S; Cen Y; Zhu T; Wang L; Xia L; Liu Y; Zou J; Xu J; Li Y; Cheng X; Lu W; Wang X; Xie X
    J Exp Clin Cancer Res; 2020 Dec; 39(1):281. PubMed ID: 33308298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glucose metabolism reprogramming in gynecologic malignant tumors.
    Ma J; Yao Z; Ma L; Zhu Q; Zhang J; Li L; Liu C
    J Cancer; 2024; 15(9):2627-2645. PubMed ID: 38577616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Role of Urothelial Cancer-Associated 1 in Gynecological Cancers.
    Nousiopoulou E; Vrettou K; Damaskos C; Garmpis N; Garmpi A; Tsikouras P; Nikolettos N; Nikolettos K; Psilopatis I
    Curr Issues Mol Biol; 2024 Mar; 46(3):2772-2797. PubMed ID: 38534790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Defining new biomarkers for overcoming therapeutical resistance in cervical cancer using lncRNA.
    Aswathy R; Sumathi S
    Mol Biol Rep; 2023 Dec; 50(12):10445-10460. PubMed ID: 37878205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Review of possible mechanisms of radiotherapy resistance in cervical cancer.
    Zhang H; Wang X; Ma Y; Zhang Q; Liu R; Luo H; Wang Z
    Front Oncol; 2023; 13():1164985. PubMed ID: 37692844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long noncoding RNA BBOX1-AS1 increased radiotherapy sensitivity in colorectal cancer by stabilizing and activating PFK1.
    Wang Q; Li XF; Zhou YH; Qin XH; Wang LH; Xiao MQ; Cao K; Ma JK; Huang CH
    Transl Oncol; 2023 Oct; 36():101751. PubMed ID: 37544035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hexokinase 2 confers radio-resistance in hepatocellular carcinoma by promoting autophagy-dependent degradation of AIMP2.
    Zheng Y; Zhan Y; Zhang Y; Zhang Y; Liu Y; Xie Y; Sun Y; Qian J; Ding Y; Ding Y; Fang Y
    Cell Death Dis; 2023 Aug; 14(8):488. PubMed ID: 37524692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long noncoding RNAs, glucose metabolism and cancer (Review).
    Hou XR; Zhang ZD; Cao XL; Wang XP
    Oncol Lett; 2023 Aug; 26(2):340. PubMed ID: 37427347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and validation of a two glycolysis-related LncRNAs prognostic signature for glioma and in vitro analyses.
    Xu X; Zhou S; Tao Y; Zhong Z; Shao Y; Yi Y
    Cell Div; 2023 Jun; 18(1):10. PubMed ID: 37355624
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aiding Cancer's "Sweet Tooth": Role of Hexokinases in Metabolic Reprogramming.
    Farooq Z; Ismail H; Bhat SA; Layden BT; Khan MW
    Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycolytic Genes Predict Immune Status and Prognosis Non-Small-Cell Lung Cancer Patients with Radiotherapy and Chemotherapy.
    Zhao T; Shao J; Liu J; Wang Y; Chen J; He S; Wang G
    Biomed Res Int; 2023; 2023():4019091. PubMed ID: 37101691
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular mechanisms of long noncoding RNAs associated with cervical cancer radiosensitivity.
    Wu S; Zhu H; Wu Y; Wang C; Duan X; Xu T
    Front Genet; 2022; 13():1093549. PubMed ID: 36685972
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long noncoding RNAs: glycolysis regulators in gynaecologic cancers.
    Lv N; Shen S; Chen Q; Tong J
    Cancer Cell Int; 2023 Jan; 23(1):4. PubMed ID: 36639695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cervical cancer heterogeneity: a constant battle against viruses and drugs.
    Sun Q; Wang L; Zhang C; Hong Z; Han Z
    Biomark Res; 2022 Nov; 10(1):85. PubMed ID: 36397138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent progress of the tumor microenvironmental metabolism in cervical cancer radioresistance.
    Zhou J; Lei N; Tian W; Guo R; Chen M; Qiu L; Wu F; Li Y; Chang L
    Front Oncol; 2022; 12():999643. PubMed ID: 36313645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Role of LncRNAs in the Regulation of Radiotherapy Sensitivity in Cervical Cancer.
    Zhang H; Fang C; Feng Z; Xia T; Lu L; Luo M; Chen Y; Liu Y; Li Y
    Front Oncol; 2022; 12():896840. PubMed ID: 35692795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance.
    Yao T; Yao Y; Chen Z; Peng Y; Zhong G; Huang C; Li J; Li R
    Cancer Cell Int; 2022 Apr; 22(1):165. PubMed ID: 35477450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exploring clinical implications and role of non-coding RNAs in lung carcinogenesis.
    Roy S; Ganguly N; Banerjee S
    Mol Biol Rep; 2022 Jul; 49(7):6871-6883. PubMed ID: 35076850
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HK2 Is a Crucial Downstream Regulator of miR-148a for the Maintenance of Sphere-Forming Property and Cisplatin Resistance in Cervical Cancer Cells.
    Yang H; Hou H; Zhao H; Yu T; Hu Y; Hu Y; Guo J
    Front Oncol; 2021; 11():794015. PubMed ID: 34858863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Competitive Endogenous Role of the LINC00511/miR-185-3p Axis and miR-301a-3p From Liquid Biopsy as Molecular Markers for Breast Cancer Diagnosis.
    Mahmoud MM; Sanad EF; Elshimy RAA; Hamdy NM
    Front Oncol; 2021; 11():749753. PubMed ID: 34745973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.